Evidence map›Paper›PMID 35110607›Full record

ArticleScientific reports2022

Construction of a femininity score in the UK Biobank and its association with angina diagnosis prior to myocardial infarction.

Anna Levinsson, Simon de Denus, Johanna Sandoval, Louis-Philippe Lemieux Perreault, Joëlle Rouleau, Jean-Claude Tardif, Julie Hussin, Marie-Pierre Dubé

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Disentangling the effects of sex and gender onAlzheimer's & dementia (Amsterdam, Netherlands)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anna LevinssonBeaulieu-Saucier Université de Montréal Pharmacogenomics Centre, Montreal, QC, Canada. anna.le.levinsson@gmail.com.
Simon de DenusBeaulieu-Saucier Université de Montréal Pharmacogenomics Centre, Montreal, QC, Canada.
Johanna SandovalBeaulieu-Saucier Université de Montréal Pharmacogenomics Centre, Montreal, QC, Canada.
Louis-Philippe Lemieux PerreaultBeaulieu-Saucier Université de Montréal Pharmacogenomics Centre, Montreal, QC, Canada.
Joëlle RouleauFaculty of Arts and Sciences, Université de Montréal, Montreal, QC, Canada.
Jean-Claude TardifBeaulieu-Saucier Université de Montréal Pharmacogenomics Centre, Montreal, QC, Canada.
Julie HussinMontreal Heart Institute, Montreal, QC, Canada.
Marie-Pierre DubéBeaulieu-Saucier Université de Montréal Pharmacogenomics Centre, Montreal, QC, Canada. marie-pierre.dube@umontreal.ca.

Funding

British Heart Foundation CH/1996001/9454Medical Research Council MC_PC_17228Medical Research Council MC_QA137853
6 · The paper itself

Abstract

Gender captures social components beyond biological sex and can add valuable insight to health studies in populations. However, assessment of gender typically relies on questionnaires which may not be available. The aim of this study is to construct a gender metric using available variables in the UK Biobank and to apply it to the study of angina diagnosis. Proxy variables for femininity characteristics were identified in the UK Biobank and regressed on sex to construct a composite femininity score (FS) validated using tenfold cross-validation. The FS was assessed as a predictor of angina diagnosis before incident myocardial infarction (MI) events. The FS was derived for 315,937 UK Biobank participants. In 3059 individuals with no history of MI at study entry who had an incident MI event, the FS was a significant predictor of angina diagnosis prior to MI (OR 1.24, 95% CI 1.10-1.39, P < 0.001) with a significant sex-by-FS interaction effect (P = 0.003). The FS was positively associated with angina diagnosis prior to MI in men (OR 1.37, 95% CI 1.19-1.57, P < 0.001), but not in women. We have provided a new tool to conduct gender-sensitive analyses in observational studies, and applied it to study of angina diagnosis prior to MI.

Indexed as

FemininityAngina PectorisBiological Specimen BanksFemaleHumansMaleMiddle AgedMyocardial InfarctionRisk AssessmentRisk FactorsSex FactorsUnited Kingdom

Identifiers

PMID35110607
PMCPMC8810762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.